Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue

Journal of Vascular Research

Volumn 34, Issue 3, 1997, Pages 237-243

  Harder, David R ^a,b   Lange, Andrew R ^a,b   Gebremedhin, Debebe ^a,b   Birks, Eric K ^a,b   Roman, Richard J ^a,b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Clement J Zablocki Veterans Medical Center   (United States)

Author keywords

20 Hydroxyeicosatetraenoic acid; Arachidonic acid; Cytochrome P450; Second messenger; Vascular smooth muscle

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; HYDROXYICOSATETRAENOIC ACID; NITRIC OXIDE; POTASSIUM CHANNEL;

AUTOREGULATION; BLOOD FLOW; BLOOD VESSEL TONE; CALCIUM CURRENT; CONFERENCE PAPER; HUMAN; NONHUMAN; PRIORITY JOURNAL; SECOND MESSENGER; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

EID: 0031002404     PISSN: 10181172     EISSN: 14230135     Source Type: Journal    
DOI: 10.1159/000159228     Document Type: Article

References (35)

1. Harder DR, Campbell WB, Roman JR.: Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control vascular lone, J Vase Res 1995;32:79-92.
2. McGiff JC: Cytochrome P450 metabolites of arachidonic acid, Annu Rev Pharmacol Toxicol 1991;31:339-369.
3. Narayanan J, Imig M, Roman RJ, Harder DR: Pressurization of isolated renal arteries increases inositol triphosphate and diacylglycer-ol, Am J Physiol 1994:266:H1840-H1845.
4. Mathias S, Kolesnick R: Ceramidc: A novel second messenger, Adv Lipid Res 1993:25:65-90.
5. Dennis EA, Rhee SG, Billah MM, Hannun YA: Role of phospholipasc in generating lipid second messengers in signal transduction, FASEB J 1991:5:2068-2077.
6. Gräber R, Sumida C, Nunez EA: Fatty acids and cell signal transduction, J Lipid Médiat Cell Signalling 1994;9:91-116.
7. Harder DR, Gebremedhin D, Narayanan J, Jefcoate C, et al: Formation and action of a P-450 metabolite of arachidonic acid in cat cerebral microvessels, Am J Physiol 1994:266: H2098-H2107.
8. Roman RJ, Harder DR: Cytochrome P450 metabolites of arachidonic acid in the control of vascular tone; in Rubanyi GM (ed): Mechano-reception by the Vascular Wall, Mount Kisco, Futura, 1993, pp 986-996.
9. Johnson EF, Walker DL, Griffin KJ: Cloning and expression of three rabbit kidney cDNAs encoding lauric acid omega-hydroxylases, Biochemistry 1990;29:873-879.
10. Aoyoma T, Hardwick JP, Imaoka S, Funae Y, et al: Clofibratc-induced rat hepatic IVA I and IVA3 catalyze the to- and (co-1)-hydroxylation of fatty acids and the io-hydroxylation of prostaglandin Ei and F^, J Lipid Res 1990;31: 1477-1782.
11. Imig DJ, Zou A-P, Stec DE, Harder DR, Falck JR., Roman RJ: Formation and actions of 20-hydroxyeicosatetraenoic acid in rat renal arterioles, Am J Physiol 1996;270:R217-R227.
12. Zou AP, Imig J D, Kaldunski M, Ortiz dc Montellano PR, Sui Z, Roman RJ: Inhibition of renal vascular 20-HETE production impairs autorcgulation of renal blood flow, Am J Physiol 1994;266:F275-F284.
13. Ma Y-H, Gebremedhin D, Schwartzman ML, Falck JR., Clark JE, Masters BS, Harder DR, Roman RJ: 20-hydroxyeicosatetracnoic acid is an endogenous vasoconstrictor of canine renal arcuate arteries, Circ Res 1993;72:126-136.
14. Makita K, Falck JR., Capdevila JH: Cytochrome P450, the arachidonic cascade, and hypertension: New vista for an old enzyme system, FASEBJ 1996;10:1456-1463.
15. Escalante B, Ornata K, Sessa W, Lee S-G, Falck JR., Schwartzman ML: 20-Hydroxycicosaletra-enoic acid is an endothelium-dependent vasoconstrictor in rabbit arteries, Eur J Pharmacol 1993:235:1-7.
16. Schwartzman ML, Falck JR., Yadagiri P, Escalante B: Metabolism of 20-hydroxyeicosatetra-enoic acid by cyclooxvgenase: Formation and identification of novel endothelium dependent vasoconstrictor metabolite, J Biol Chem 1989; 264:11658-11662.
17. Oyckan AO: role of the cytochrome P450 enzyme system as a humoral modulator of vasomotor responses in the rat renal vasculature, J Cardiovasc Pharmacol 1990:24:238-246.
18. Zou AP, Fleming JT, Falck JR., Jacobs ER, Gebremedhin D, Harder DR, Roman RJ: 20-Hydroxyeicosatetraenoic acid is an endogenous inhibitor of the large conductance Ca++-activated K+ channel in renal arterioles, Am J Physiol 1996;270:R228-R237.
19. Sun C, Harder DR, Roman RJ: Inhibitory action of 20-HETE on Ca-activatcd K+ channel may involve a G-protein dependent mechanism (abstract), FASEB J 1997; 11:A503.
20. Meininger GA, Davis MJ: Cellular mechanisms involved in the vascular myogenic response, Am J Physiol 1992:263:H647-H659.
21. Kauser K, Clark JE, Masters BS, Ortiz de Mon-tcllano PR, Ma Y-H, Harder DR, Roman RJ: Inhibitors of cytochrome P-450 attenuate the myogenic response of dog renal arcuate arteries, Circ Res 1991:68:1154-1163.
22. Imig J, Zou AP, Ortiz de Montellano, Sui Z, Roman RJ: Inhibitors of cytochrome p450 alter the afferent arteriolar reponses to elevations in pressure, Am J Physiol 1994;266:H1879-H1885.
23. Zou AP, Ma YH, Ortiz de Montellano, Clark JE, Masters BSS, Roman RJ: Effects of 17-ODYA, a suicide substrate inhibitor of P450 fatty acid hydroxylase on renal function of rats, J Pharmacol ExpTher 1994,268:474-481.
24. Alonso-Galicia M, Drummond HA, Reddy KK, Falck JR., Roman RJ: Inhibition of 20-HETE production contributes to the renal and peripheral vascular responses to nitric oxide, Hypertension 1997;29:320-325.
25. Hursham AR, Marietta MA: Nitric oxide complexes of inducible nitric oxide synthase: Spectral characterization and effect on catalytic activity, Biochemistry 1995;34:5627-5634.
26. Griscavagc JM, Hobbs AJ, Ignarro LJ: Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds, Adv Pharmacol 1995;34:215-234.
27. Khalsenko OG, Gross SS, Rifkind AB, Vane JR.: Nitric oxide is a mediator of the decrease in cytochrome P450-depcndent metabolism caused by immunostimulants, Proc Natl Acad Sci 1993:90:11147-11151.
28. Wink DA, Osawa Y, Darbyshirc JF, Jones CR, Eshenaus SC, Nims RW: Inhibition of cytochrome P450 by nitric oxide and a nitric oxide releasing agent, Arch Biochcm Biophys 1993; 300:115-123.
29. Duthu GS, Schertzer HG, Effect of nitrate on rabbit liver mixed function oxidase activity, DrugMetab Dispos 1979:7:263-269.
30. Schertzer HG, Duthu GS: Nitrite binding to rabbit liver microsome and effects of aminopy-rine déméthylation, Biochem Pharmacol 1979: 28:873-879.
31. Wang D, Hsu K, Hwang C-P, Chen HI: Measurement of NO release in the isolated perfused rat lung, Biochem Biophys Res Commun 1987: 139:19-30.
32. Zou A-P, Cowley AW Jr.: Nitric oxide in the renal cortex and medulla: An in vivo microdialysis study, Hypertension 1997:29:194-198.
33. Cohen RA, Vanhoutte PM: Endothelium-dependent hypcrpolarization beyond nitric oxide and cyclic GMP, Circulation 1995:92:3337-3349.
34. Hecker M, Bara AT, Bauersachs J, Busse R: Characterization of endothelium-derived hy-perpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals, J Physiol 1994;481:407-414.
35. Campbell WB, Gebremedhin D, Pratt PF, Harder DR: Identification of epoxyeicosatri-enoic acids as endothelium-derived hyperpo-larizing factors, Circ Res 1996:78:415-423.